Patent · US Active

Substituted nucleosides, nucleotides and analogs thereof

US9758544B2 · kind B2 · utility

19Cited by
3References
54Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2015
Grant dateSep 12, 2017
Priority date
Expiry dateDec 16, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/07048
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.